DE69728206T2 - Herstellungsverfahren für Carotenoid-Zusammensetzungen - Google Patents

Herstellungsverfahren für Carotenoid-Zusammensetzungen Download PDF

Info

Publication number
DE69728206T2
DE69728206T2 DE69728206T DE69728206T DE69728206T2 DE 69728206 T2 DE69728206 T2 DE 69728206T2 DE 69728206 T DE69728206 T DE 69728206T DE 69728206 T DE69728206 T DE 69728206T DE 69728206 T2 DE69728206 T2 DE 69728206T2
Authority
DE
Germany
Prior art keywords
carotenoid
suspension
powder
aqueous
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69728206T
Other languages
German (de)
English (en)
Other versions
DE69728206D1 (de
Inventor
Ray Edward Lake Hiawatha Kowalski
William Joseph West Caldwell Mergens
Leonard Joseph Andover Scialpi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of DE69728206D1 publication Critical patent/DE69728206D1/de
Application granted granted Critical
Publication of DE69728206T2 publication Critical patent/DE69728206T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69728206T 1996-05-14 1997-04-26 Herstellungsverfahren für Carotenoid-Zusammensetzungen Expired - Lifetime DE69728206T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17568 1993-02-16
US1756896P 1996-05-14 1996-05-14

Publications (2)

Publication Number Publication Date
DE69728206D1 DE69728206D1 (de) 2004-04-29
DE69728206T2 true DE69728206T2 (de) 2005-03-10

Family

ID=21783319

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728206T Expired - Lifetime DE69728206T2 (de) 1996-05-14 1997-04-26 Herstellungsverfahren für Carotenoid-Zusammensetzungen

Country Status (10)

Country Link
US (1) US6093348A (enExample)
EP (1) EP0807431B1 (enExample)
JP (1) JP3961070B2 (enExample)
CN (1) CN1079212C (enExample)
AT (1) ATE262316T1 (enExample)
BR (1) BR9703134A (enExample)
DE (1) DE69728206T2 (enExample)
DK (1) DK0807431T3 (enExample)
ES (1) ES2216079T3 (enExample)
IN (1) IN183685B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015346A1 (de) * 2016-07-19 2018-01-25 Basf Se Propylgallathaltige vitaminzubereitungen

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69724231T3 (de) * 1996-01-22 2012-09-20 Chr. Hansen A/S In wasser dispergierbare zusammensetzungen, die ein natuerliches hydrophobes pigment enthalten, verfahren zu ihrer herstellung und ihre verwendung
HUP0105089A3 (en) 1998-11-20 2002-09-30 Skyepharma Canada Inc Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
EP1276465B1 (en) * 2000-04-20 2014-03-12 Jagotec AG Improved water-insoluble drug particle process
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
AU2001262945B2 (en) * 2000-09-20 2006-02-02 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
DE10064387A1 (de) 2000-12-21 2002-06-27 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Sauerstoff-haltiger Carotinoide
WO2002077105A1 (en) * 2001-03-22 2002-10-03 Fuji Chemical Industry Co., Ltd. Stable astaxanthin-containing powdery compositions and process for producing the same
US6811801B2 (en) * 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US7901708B2 (en) 2002-06-28 2011-03-08 Protiva Biotherapeutics, Inc. Liposomal apparatus and manufacturing methods
CA2495167C (en) * 2002-07-29 2018-08-21 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
JP4773337B2 (ja) 2003-03-27 2011-09-14 ディーエスエム アイピー アセッツ ビー．ブイ． ビーズレットの製造方法
US7110827B2 (en) * 2003-04-25 2006-09-19 Medtronic, Inc. Electrical connectors for medical lead having weld-less wiring connection
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US7691901B2 (en) * 2004-04-14 2010-04-06 Cardax Pharmaceuticals Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
JP4562174B2 (ja) * 2004-08-23 2010-10-13 カゴメ株式会社 カロテノイド含有物の製造方法
AU2005279201B2 (en) * 2004-08-31 2011-08-04 Akzo Nobel N.V. Method for pigment solubilisation, a pigment composition and its use
US10463061B2 (en) * 2004-11-19 2019-11-05 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
US8755258B2 (en) 2005-02-16 2014-06-17 Mitsubishi Electric Corporation Optical disc and optical disc device
CN100421650C (zh) * 2005-03-23 2008-10-01 浙江新和成股份有限公司 水分散性类胡萝卜素粉的制备方法
EP1937213B1 (en) * 2005-07-27 2017-10-25 Protiva Biotherapeutics Inc. Systems and methods for manufacturing liposomes
WO2007020057A1 (en) * 2005-08-15 2007-02-22 Phares Pharmaceutical Research N.V. Crystal forms of astaxanthin
US7435846B2 (en) 2006-08-18 2008-10-14 Industrial Organica, S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
AU2008225781B2 (en) * 2007-03-15 2013-09-12 Dsm Ip Assets B.V. Stabilized micronised particles
WO2009093595A1 (ja) * 2008-01-25 2009-07-30 Fujifilm Corporation カロテノイド含有エマルション組成物の製造方法、それにより得られるカロテノイド含有エマルション組成物並びにカロテノイド含有粉末組成物、該組成物を含む機能性食品及び化粧品
EP2210593A3 (en) 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
WO2011030816A1 (ja) 2009-09-14 2011-03-17 国立大学法人北海道大学 抗植物ウイルス剤
CN107006752A (zh) * 2010-06-08 2017-08-04 三荣源有限公司 含类胡萝卜色素乳化制剂和含该制剂的食品及其制造方法
JP5600513B2 (ja) * 2010-07-29 2014-10-01 理研ビタミン株式会社 クロセチン製剤の製造方法
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
WO2012031129A2 (en) 2010-09-03 2012-03-08 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
EP2642872A1 (en) 2010-11-26 2013-10-02 DSM IP Assets B.V. Protective hydrocolloid for active ingredients
US20120157547A1 (en) 2010-12-21 2012-06-21 Ricardo Montoya-Olvera Compositions and applications of carotenoids of improved absorption and bioavailability
KR102221655B1 (ko) * 2012-10-18 2021-03-03 디에스엠 아이피 어셋츠 비.브이. 카로티노이드를 포함하는 비들렛
WO2015044222A1 (en) * 2013-09-24 2015-04-02 Dsm Ip Assets B.V. Stable formulations for coloring beverages and food products
JP6650933B2 (ja) 2014-10-31 2020-02-19 ベンド リサーチ， インコーポレイテッド マトリックス中に分散された活性薬剤ドメインを形成するためのプロセス
CN108777979A (zh) * 2016-03-15 2018-11-09 帝斯曼知识产权资产管理有限公司 包衣颗粒
JP6954917B2 (ja) * 2016-03-24 2021-10-27 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 多相活性物質調製物
US12491261B2 (en) 2016-10-26 2025-12-09 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
US11197493B2 (en) * 2017-09-12 2021-12-14 Omniactive Health Technologies Limited Stabilized fat soluble nutrient compositions and process for the preparation thereof
JP7225820B2 (ja) 2019-01-21 2023-02-21 株式会社アイシン 車両用開閉体制御装置
KR20220024544A (ko) * 2019-06-17 2022-03-03 디에스엠 아이피 어셋츠 비.브이. 메트포르민 및 칼슘 시트레이트를 포함하는 약학적 투여 형태
CN114025745A (zh) * 2019-06-17 2022-02-08 帝斯曼知识产权资产管理有限公司 包含盐酸二甲双胍、维生素b12和至少一种流动助剂的组合物
EP3982936A1 (en) * 2019-06-17 2022-04-20 DSM IP Assets B.V. Solid pharmaceutical dosage form comprising spray dried vitamin b12
CN112438950A (zh) * 2019-08-16 2021-03-05 北京化工大学 一种β-胡萝卜素透明水分散液及其制备方法
CN111471317B (zh) * 2020-03-26 2021-06-04 广东省农业科学院蚕业与农产品加工研究所 一种稳态化玉米黄色素及其制备方法
CN111838648B (zh) * 2020-06-16 2023-04-25 嘉必优生物技术（武汉）股份有限公司 一种生产纳米级类胡萝卜素乳液的装置及方法
AU2021308681A1 (en) 2020-07-16 2023-03-09 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles
CN112841645A (zh) * 2021-01-14 2021-05-28 江南大学 一种β-胡萝卜素微胶囊的制备方法
CN113426355A (zh) * 2021-06-25 2021-09-24 骏马化纤股份有限公司 一种化纤生产用油剂乳液自动化控制系统及制备方法
CN118647600A (zh) 2021-12-16 2024-09-13 爱康泰生治疗公司 用于脂质纳米颗粒制剂的脂质
CN118525919A (zh) * 2023-02-22 2024-08-23 浙江可明生物医药有限公司 类胡萝卜素制剂的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
US2861891A (en) * 1956-12-13 1958-11-25 Hoffmann La Roche Water dispersible carotenoid compositions and process of making the same
DE1211911B (de) * 1959-09-08 1966-03-03 Hoffmann La Roche Verfahren zur Herstellung eines insbesondere zum Faerben von Lebens- und Futtermitteln geeigneten Carotinoidpraeparates
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4908154A (en) * 1981-04-17 1990-03-13 Biotechnology Development Corporation Method of forming a microemulsion
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
DE3119383A1 (de) * 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
DE3702031A1 (de) * 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
ATE96312T1 (de) * 1989-07-25 1993-11-15 Hoffmann La Roche Verfahren zur herstellung von carotinoidpraeparaten.
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
DK19393D0 (da) * 1993-02-19 1993-02-19 Danochemo As Fremgangsmaade til fremstilling af et i vand dispergerbart pulverformigt carotenoidpraeparat
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
DE19649062A1 (de) * 1996-11-27 1998-05-28 Basf Ag Flüssige, mit Öl mischbare Carotinoid-Zubereitungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015346A1 (de) * 2016-07-19 2018-01-25 Basf Se Propylgallathaltige vitaminzubereitungen
US10835456B2 (en) 2016-07-19 2020-11-17 Basf Se Propyl gallate-containing vitamin preparations

Also Published As

Publication number Publication date
ATE262316T1 (de) 2004-04-15
CN1176760A (zh) 1998-03-25
JP3961070B2 (ja) 2007-08-15
US6093348A (en) 2000-07-25
IN183685B (enExample) 2000-03-18
DE69728206D1 (de) 2004-04-29
DK0807431T3 (da) 2004-07-26
EP0807431B1 (en) 2004-03-24
EP0807431A2 (en) 1997-11-19
ES2216079T3 (es) 2004-10-16
EP0807431A3 (en) 1998-08-12
CN1079212C (zh) 2002-02-20
BR9703134A (pt) 1998-08-18
JPH1046041A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
DE69728206T2 (de) Herstellungsverfahren für Carotenoid-Zusammensetzungen
DE69403069T2 (de) Verfahren zum herstellung einer wasserdiepergierbaren pulverfoermigen carotenoidzubereitung
EP0410236B1 (de) Verfahren zur Herstellung von Carotinoidpräparaten
DE69006362T3 (de) Verfahren zur herstellung eines wasserdispergierbaren hydrophobischen oder aerophilen festkörpers.
EP0065193B1 (de) Verfahren zur Herstellung von feinverteilten, pulverförmigen Carotinoid- bzw. Retinoidpräparaten
DE69929641T2 (de) Herstellung eines fein verteilten, pulverförmigen Carotinoidpräparats
EP1898721B1 (de) Verfahren zur herstellung einer wässrigen suspension und einer pulverförmigen zubereitung eines oder mehrerer carotinoide
EP0239949B1 (de) Verfahren zur Herstellung von feinverteilten, pulverförmigen Carotinoidpräparaten
EP1794238B1 (de) Verfahren zur herstellung von trockenpulvern eines oder mehrerer carotinoide
DE60320380T2 (de) Coenzym q10 formulierungen
EP2188250B1 (de) Verfahren zur herstellung von öligen lösungen von astaxanthin-derivaten
EP0982038B1 (de) Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Vefahren zu deren Herstellung
DE10104494A1 (de) Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide
EP1219292A1 (de) Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Sauerstoff-haltiger Carotinoide
EP2403359B1 (de) Pulverförmige zusammensetzung von astaxanthin-derivaten i
EP2222180B1 (de) Verfahren zur herstellung von carotinoid-lösungen
EP2403364B1 (de) Verfahren zur herstellung von lösungen von astaxanthin-derivaten
EP2403354A1 (de) Formulierung von astaxanthin-derivaten und deren verwendung i
DE60200619T2 (de) Verfahren zur Herstellung einer Carotinoid-Emulsion
EP2403361B1 (de) Verfahren zur herstellung von carotinoid-lösungen
EP2403363A1 (de) Formulierung von astaxanthin-derivaten und deren verwendung ii
EP1270679B9 (de) Farbstoff-Gemisch, seine Herstellung sowie Verwendung in Lebensmitteln, Pharmazeutika und Kosmetika
WO2009065928A1 (de) Verfahren zur herstellung von carotinoidlösungen
DE2004312C3 (de) Färbepräparat, dessen Herstellung und Verwendung
DE102008058446A1 (de) Verfahren zur Herstellung von Carotinoid-Lösungen V

Legal Events

Date Code Title Description
8364 No opposition during term of opposition